MedRhythms secures funds to develop digital therapeutics platform
The series A financing round was led by Peter Werth of Werth Family, Investment Associates and the participants include investors, executives, and CEO. The company will use the
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XThe series A financing round was led by Peter Werth of Werth Family, Investment Associates and the participants include investors, executives, and CEO. The company will use the
Zephyr system is claimed to be the first minimally-invasive device approved in the US to treat severe emphysema, a progressive and life-threatening form of chronic obstructive pulmonary disease
The next-generation family of Sniper devices will deliver pressure-directed therapy for tumors, enlarged prostate and fibroids. Sniper balloon occlusion microcatheter will help physicians to improve access and navigate
The partnership will apply Philips EMaaS model to help health system adopt advanced patient monitoring systems for a per-patient fee. It will also help to enhance patient safety
The partnership will apply near infrared imaging technology with Kent’s KD203 tissue oxygenation assessment device to improve tissue assessment in wounds. Kent Imaging CEO Pierre Lemire said: “Our joint
The company has raised the series B financing from existing investors to be used for the elimination of extraneous trips to the optometrist and make at-home vision testing
The Impede embolization plug has been developed to block or reduce the rate of blood flow in the peripheral vasculature. The company is providing the embolization plug in
The system has been approved to treat people with type 1 diabetes aged seven years and older with ongoing studies to expand the indication to additional patient populations.
The device has showed significant clinical benefits in patients with type 2 diabetes in the effectiveness of V-Go wearable insulin delivery for basal-bolus therapy (ENABLE) study. Valeritas’ first
The new minimally invasive technology is said to use magnetic catheters and radiofrequency energy to create an arteriovenous fistula (AVF) for hemodialysis access without open surgery. The FDA